Skip to content
Riskpilot
← Back to search
Sign in
Get full access
MISSIONPHARMA A/S
A/S
Active
CVR 26902398
Vassingerødvej 9, 3540
Lynge
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2002 · 23 years old
65 employees
Monitor
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
MISSIONPHARMA A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
0M
271M
542M
812M
1B
731M
2021
694M
2022
942M
2023
940M
2024
742M
2025
EBITDA
DKK millions
198M
148M
99M
49M
0M
120M
2021
73M
-39%
2022
158M
+116%
2023
145M
-8%
2024
89M
-39%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Revenue
731.472
693.959
942.492
940.120
741.955
Staff expenses
-50.693
-48.338
-56.410
-56.972
-56.914
EBITDA
120.485
73.221
157.914
145.238
89.312
Depreciation & amort.
-1.999
-1.590
-1.550
-1.415
-1.365
EBIT
118.486
71.631
156.364
143.823
87.947
Net financials
-12.025
2.041
-3.375
8.347
5.169
Profit before tax
106.461
73.672
152.989
152.170
93.116
Tax
22.854
15.690
33.830
32.305
19.714
Net profit
83.607
57.982
119.159
119.865
73.402
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
427.212
428.519
538.204
470.384
403.205
Equity
332.425
312.809
340.843
319.316
273.135
Long-term debt
0
0
427
0
0
Short-term debt
91.578
113.919
196.934
141.321
117.997
Total debt
91.578
113.919
197.361
151.068
130.070
Financial ratios
5-year trend
EBITDA margin
12.0%
This company
15.8%
Market median
-24% vs market
2021
2025
Equity ratio
67.7%
This company
38.2%
Market median
+77% vs market
2021
2025
Return on equity
26.9%
This company
18.4%
Market median
+46% vs market
2021
2025
Net profit margin
9.9%
This company
8.1%
Market median
+22% vs market
2021
2025
Asset turnover
1.84×
This company
1.12×
Market median
+64% vs market
2021
2025
Debt / equity
0.48×
This company
0.62×
Market median
+23% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2024-04-01 – 2025-03-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2023-04-01 – 2024-03-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2022-04-01 – 2023-03-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2021-04-01 – 2022-03-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2020-04-01 – 2021-03-31
View
PDF
More on MISSIONPHARMA A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
